Nampt and Its Potential Role in Inflammation and Type 2 Diabetes
- 16 February 2011
- book chapter
- Published by Springer Nature
- No. 203,p. 147-164
Abstract
Nicotinamide phosphoribosyltransferase (Nampt ) is a key nicotinamide adenine dinucleotide (NAD) biosynthetic enzyme in mammals, converting nicotinamide into nicotinamide mononucleotide (NMN ), an NAD intermediate. First identified in humans as a cytokine pre-B-cell colony enhancing factor (PBEF ) and subsequently described as an insulin-mimetic hormone visfatin , Nampt has recently excited the scientific interest of researchers from diverse fields, including NAD biology, metabolic regulation, and inflammation. As an NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses. Nampt plays an important role in the regulation of insulin secretion in pancreatic β-cells. Nampt also functions as an immunomodulatory cytokine and is involved in the regulation of inflammatory responses. This chapter summarizes the various functional aspects of Nampt and discusses its potential roles in diseases, with special focus on type 2 diabetes mellitus (T2DM).Keywords
This publication has 103 references indexed in Scilit:
- Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical MechanismsDiabetes, 2010
- Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in HumansDiabetes, 2009
- Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling MechanismJournal of Biological Chemistry, 2008
- Insulin sensitivity: modulation by nutrients and inflammationJournal of Clinical Investigation, 2008
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NADPLOS ONE, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Age‐associated loss of Sirt1‐mediated enhancement of glucose‐stimulated insulin secretion in beta cell‐specific Sirt1‐overexpressing (BESTO) miceAging Cell, 2007
- Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic EnzymeCell Metabolism, 2007
- Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary AtherosclerosisCirculation, 2007
- Nampt/PBEF/Visfatin: A regulator of mammalian health and longevity?Experimental Gerontology, 2006